BMKDF
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
Aug 27 closing price
Capitalization
25.45M
ELUT
Price
$2.33
Change
+$0.12 (+5.43%)
Updated
Aug 28 closing price
Capitalization
98.78M
80 days until earnings call
Interact to see
Advertisement

BMKDF vs ELUT

Header iconBMKDF vs ELUT Comparison
Open Charts BMKDF vs ELUTBanner chart's image
Biomark Diagnostics
Price$0.23
Change-$0.01 (-4.17%)
Volume$7.5K
Capitalization25.45M
Elutia
Price$2.33
Change+$0.12 (+5.43%)
Volume$17.71K
Capitalization98.78M
BMKDF vs ELUT Comparison Chart in %
Loading...
BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMKDF vs. ELUT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMKDF is a Hold and ELUT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BMKDF: $0.23 vs. ELUT: $2.33)
Brand notoriety: BMKDF and ELUT are both not notable
BMKDF represents the Medical Specialties, while ELUT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BMKDF: 59% vs. ELUT: 61%
Market capitalization -- BMKDF: $25.45M vs. ELUT: $98.78M
BMKDF [@Medical Specialties] is valued at $25.45M. ELUT’s [@Medical/Nursing Services] market capitalization is $98.78M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMKDF’s FA Score shows that 0 FA rating(s) are green whileELUT’s FA Score has 0 green FA rating(s).

  • BMKDF’s FA Score: 0 green, 5 red.
  • ELUT’s FA Score: 0 green, 5 red.
According to our system of comparison, ELUT is a better buy in the long-term than BMKDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMKDF’s TA Score shows that 4 TA indicator(s) are bullish while ELUT’s TA Score has 6 bullish TA indicator(s).

  • BMKDF’s TA Score: 4 bullish, 3 bearish.
  • ELUT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ELUT is a better buy in the short-term than BMKDF.

Price Growth

BMKDF (@Medical Specialties) experienced а -8.74% price change this week, while ELUT (@Medical/Nursing Services) price change was +5.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +7.40%, and the average quarterly price growth was +7.26%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.48%. For the same industry, the average monthly price growth was +6.46%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

ELUT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Medical Specialties (-0.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELUT($98.8M) has a higher market cap than BMKDF($25.4M). BMKDF YTD gains are higher at: 58.530 vs. ELUT (-37.701). BMKDF has higher annual earnings (EBITDA): -1.52M vs. ELUT (-14.01M). ELUT has more cash in the bank: 8.5M vs. BMKDF (88.6K). BMKDF has less debt than ELUT: BMKDF (547K) vs ELUT (28.2M). ELUT has higher revenues than BMKDF: ELUT (23.7M) vs BMKDF (155K).
BMKDFELUTBMKDF / ELUT
Capitalization25.4M98.8M26%
EBITDA-1.52M-14.01M11%
Gain YTD58.530-37.701-155%
P/E RatioN/AN/A-
Revenue155K23.7M1%
Total Cash88.6K8.5M1%
Total Debt547K28.2M2%
FUNDAMENTALS RATINGS
BMKDF: Fundamental Ratings
BMKDF
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMKDFELUT
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 24 days ago
71%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPAAY5.690.07
+1.25%
PT Perusahaan Gas Negara Persaro
PAYD2.96N/A
N/A
Paid, Inc.
CETXP0.23N/A
N/A
Cemtrex, Inc.
NASB34.51-0.17
-0.49%
NASB Financial, Inc.
TIAIY5.39-0.39
-6.80%
Telecom Italia S.p.A.

BMKDF and

Correlation & Price change

A.I.dvisor tells us that BMKDF and PAVM have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMKDF and PAVM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMKDF
1D Price
Change %
BMKDF100%
N/A
PAVM - BMKDF
22%
Poorly correlated
-2.90%
IOBCF - BMKDF
20%
Poorly correlated
+4.72%
LUNG - BMKDF
10%
Poorly correlated
-5.38%
ELUT - BMKDF
6%
Poorly correlated
+5.43%
BFLY - BMKDF
3%
Poorly correlated
+3.82%
More

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and RBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and RBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
+5.43%
RBOT - ELUT
31%
Poorly correlated
-3.50%
MHUA - ELUT
29%
Poorly correlated
-0.17%
HSDT - ELUT
23%
Poorly correlated
+0.40%
RPID - ELUT
23%
Poorly correlated
-1.95%
CHEK - ELUT
22%
Poorly correlated
-0.98%
More